22157.jpg
Interleukin-2 (IL-2) Inhibitor Drug Pipeline Research Report 2024
March 05, 2024 03:30 ET | Research and Markets
Dublin, March 05, 2024 (GLOBE NEWSWIRE) -- The "Interleukin-2 (IL-2) Inhibitor - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides...
Emergen logo.png
Protein Engineering Market Size to Reach USD 11.22 Billion in 2032 | Emergen Research
December 04, 2023 08:52 ET | Emergen Research
Vancouver, Dec. 04, 2023 (GLOBE NEWSWIRE) -- The global Protein Engineering Market is expected to reach USD 11.22 Billion by 2032, according to a new report by Emergen Research. The growth of this...
Global Autoimmune Treatment Market
Global Autoimmune Treatment Market Report 2023: Increasing Investments in Research and Development of Drugs for Autoimmune Diseases Drives Growth
May 09, 2023 10:28 ET | Research and Markets
Dublin, May 09, 2023 (GLOBE NEWSWIRE) -- The "Autoimmune Treatment Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists,...
Global Interferons Market
Interferons Global Market Research Report 2023: Focus on Polypeptides, Cytokine, and Cell-surface Receptors - A $9.92 Billion Market by 2026 with Long-term Forecasts to 2032
March 27, 2023 10:23 ET | Research and Markets
Dublin, March 27, 2023 (GLOBE NEWSWIRE) -- The "Interferons Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global interferons market is expected to grow...
pegylated-proteins-market-size.jpg
Global PEGylated Proteins Market Analysis & Industry Trends Report 2022: A $2.1 Billion Market by 2028 - Focus on Colony-stimulating Factor, Interferons, Recombinant Factor VII, & Erythropoietin
March 22, 2023 10:13 ET | Research and Markets
Dublin, March 22, 2023 (GLOBE NEWSWIRE) -- The "Global PEGylated Proteins Market Size, Share & Industry Trends Analysis Report By Product & Services, By Type (Colony-stimulating Factor,...
Global Market for Competent Cells
Global Competent Cells Strategic Business Report 2023: Increasing Research on Cloning Demands Competent Cells Requirement
February 03, 2023 11:23 ET | Research and Markets
Dublin, Feb. 03, 2023 (GLOBE NEWSWIRE) -- The "Competent Cells - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Competent Cells...
22157.jpg
Global Latent Tuberculosis Infection (LTBI) Testing Market Report 2022: A Potential $2.47 Billion Industry by 2027 - Accelerating TB Funding & Escalating Government Initiatives
September 29, 2022 05:13 ET | Research and Markets
Dublin, Sept. 29, 2022 (GLOBE NEWSWIRE) -- The "Global Latent Tuberculosis Infection (LTBI) Testing Market: Analysis By Type (Tuberculin Skin Test LTBI Testing and Interferon Gamma Released Assay...
Next Move Strategy Consulting.png
Global Biopharmaceutical Market to Generate USD 974.48 Billion by 2030, Outlines a New Report by Next Move Strategy Consulting
August 02, 2022 06:41 ET | Next Move Strategy Consulting
New York, Aug. 02, 2022 (GLOBE NEWSWIRE) -- According to the report published by Next Move Strategy Consulting, the global biopharmaceutical market generated USD 345.84 billion in 2021, and is...
22157.jpg
Multiple Sclerosis Global Market Analysis: Historical Data 2016-2020 and Forecasts for 2021-2026
February 25, 2022 04:03 ET | Research and Markets
Dublin, Feb. 25, 2022 (GLOBE NEWSWIRE) -- The "Global Multiple Sclerosis Market - Analysis By Drug Class, Route of Administration, Distribution Channel, By Region, By Country: Market Insights,...
22157.jpg
Global Multiple Sclerosis Drugs Market Report 2021: Market is Expected to Reach $25.95 Billion in 2025 - Long-term Forecast to 2030
December 13, 2021 06:53 ET | Research and Markets
Dublin, Dec. 13, 2021 (GLOBE NEWSWIRE) -- The "Multiple Sclerosis Drugs Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. ...